> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Since Our Last Issue ...
- URL: https://www.fdaweb.com/since-our-last-issue-98/
- Published: 2017-07-09T12:00:00.000Z
- Updated: 2026-09-14T22:32:47.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5139094

**SleepQuest**, a provider of care management services for obstructive sleep apnea, has acquired **Grove Medical Equipment** based in Alameda, CA. SleepQuest closed the transaction 6/30 and began serving the former customers of Grove Medical 7/1.

**ThermoGenesis** has entered into an asset acquisition agreement with **SynGen**, a privately-held Sacramento, CA-based technology company active in the cellular processing field. Under the agreement, ThermoGenesis acquired substantially all of SynGen’s operating assets, including its proprietary cell processing platform technology. In exchange, ThermoGenesis granted SynGen 20% of its common stock and paid a one-time cash payment of $1 million.

**Entellus Medical** has entered into a definitive agreement to acquire **Spirox**, a privately-held medical technology company that develops, manufactures and markets the Latera Absorbable Nasal Implant for treating nasal airway obstruction. Under the agreement, Entellus will acquire Spirox for $25 million in cash and 3.4 million shares of Entellus common stock, plus additional contingent payments over four years based on revenue growth.